Evolving immunosuppressive microenvironment during human cervical carcinogenesis

被引:127
作者
Kobayashi, A. [1 ]
Weinberg, V. [2 ]
Darragh, T. [3 ]
Smith-McCune, K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, UCSF Comprehens Canc Ctr Biostat Core, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
关键词
D O I
10.1038/mi.2008.33
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic infection with human papillomavirus (HPV) can result in cervical cancer. To understand how HPV escapes immune eradication, we examined biophenotypes of immune cells in human normal cervix, cervical intraepithelial neoplasia (CIN), and cancer. Expression and cellular localization of Forkhead box protein-3 (FOXP3), indolamine 2,3-dioxygenase (IDO), interleukin (IL)-10, and interferon (IFN)-gamma were examined by immunofluorescence and immunohistochemistry. Mean cell densities of stromal FOXP3+ cells, IDO+ cells, IL-10+ cells, CD1a+ cells, and macrophages significantly increased from normal cervix to cancer, whereas densities of IFN-gamma+ and MMP-9+ cells increased from normal cervix to CIN but decreased in cancer. Flow cytometry confirmed significant elevation of cervical T cells expressing IFN-gamma and transforming growth factor-beta in CIN compared with normal cervix. Upon activation, a significantly increased proportion of cervical T cells expressed IFN-gamma in CIN than normal. A unique subset of morphologically immature stromal dendritic cells expressing IL-10 and IDO was more numerous in cancer than in normal cervix and CIN. The potentially suppressive immune milieu in the cervix may be permissive of HPV-associated cervical carcinogenesis.
引用
收藏
页码:412 / 420
页数:9
相关论文
共 48 条
[1]  
ALSALEH W, 1995, VIRCHOWS ARCH, V427, P41
[2]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[3]   Cancer - An inflammatory link [J].
Balkwill, F ;
Coussens, LM .
NATURE, 2004, 431 (7007) :405-406
[4]   Regulation of immune responses by L- arginine metabolism [J].
Bronte, V ;
Zanovello, P .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (08) :641-654
[5]   Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection [J].
Clerici, M ;
Merola, M ;
Ferrario, E ;
Trabattoni, D ;
Villa, ML ;
Stefanon, B ;
Venzon, DJ ;
Shearer, GM ;
DePalo, G ;
Clerici, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (03) :245-250
[6]   IMMUNOLOGICAL EVENTS IN REGRESSING GENITAL WARTS [J].
COLEMAN, N ;
BIRLEY, HDL ;
RENTON, AM ;
HANNA, NF ;
RYAIT, BK ;
BYRNE, M ;
TAYLORROBINSON, D ;
STANLEY, MA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (06) :768-774
[7]   The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions [J].
Daniel, B ;
Rangarajan, A ;
Mukherjee, G ;
Vallikad, E ;
Krishna, S .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :1095-1101
[8]   The immunobiology of cancer immunosurveillance and immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
IMMUNITY, 2004, 21 (02) :137-148
[9]   HUMAN PAPILLOMAVIRUS TYPE-16 (HPV-16) GENE-EXPRESSION AND DNA-REPLICATION IN CERVICAL NEOPLASIA - ANALYSIS BY INSITU HYBRIDIZATION [J].
DURST, M ;
GLITZ, D ;
SCHNEIDER, A ;
ZURHAUSEN, H .
VIROLOGY, 1992, 189 (01) :132-140
[10]  
El-Sherif AM, 2001, J PATHOL, V195, P179, DOI 10.1002/path.929